Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis.
Factors influencing the serum concentrations of low molecular weight proteins (LMWP) during long-term hemodialysis were studied in 112 patients undergoing dialysis for an average of 61.1 months (range 1 to 243). These patients were treated with AN69, cellulose acetate, cuprophan or polysulfone membranes. The following proteins were measured in serum before and after a four hour dialysis session: cystatin C (CYST C), beta 2-microglobulin (beta 2 m), Clara cell protein (CC16) and retinol-binding protein (RBP). Predialysis levels of the four proteins were markedly elevated. In simple regression analysis, pre-dialysis serum concentrations of beta 2 m and CC16 weakly correlated with the duration of dialysis treatment, but these relations completely disappeared when a stepwise regression analysis was performed using as predictors age, sex, residual diuresis, body weight loss (BWL), duration of hemodialysis and the type or ultrafiltration coefficient (UFC) of the membranes. The only significant determinants which emerged from this analysis were the residual diuresis and age which negatively correlated with CYST C, beta 2m and CC16 (residual diuresis only), and sex which influenced CYST C. During the dialysis session, the microproteins underwent changes that were related to their molecular radius, the membrane UFC and the BWL. After adjustment for the latter, high flux membranes (UFC > or = 15 ml/h.m2.mm Hg) allowed up to 50% of CYST C and 25% of beta 2m to be removed. No significant elimination of CC16 and RBP was evident. On the basis of these results, we estimated the effective pore radius of high flux membranes between 1.5 and 1.7 nm and that of low flux membranes as below 1.5 nm.(ABSTRACT TRUNCATED AT 250 WORDS)
Kabanda
A
A
Industrial Toxicology and Occupational Medicine Unit, Catholic University of Louvain, Medical School, Brussels, Belgium.
Jadoul
M
M
Pochet
J M
JM
Lauwerys
R
R
van Ypersele de Strihou
C
C
Bernard
A
A
D001798:Blood Proteins / Q000032:analysis*; D002850:Chromatography, Gel; D055316:Cystatin C; D015891:Cystatins / Q000097:blood; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D008970:Molecular Weight; D011506:Proteins / Q000032:analysis; D006435:Renal Dialysis / Q000379:methods; D012177:Retinol-Binding Proteins / Q000032:analysis; D014598:Uteroglobin; D001613:beta 2-Microglobulin / Q000032:analysis
D001798:Blood Proteins; C525030:CST3 protein, human; D055316:Cystatin C; D015891:Cystatins; D008567:Membranes, Artificial; D011506:Proteins; D012177:Retinol-Binding Proteins; C556389:SCGB1A1 protein, human; D001613:beta 2-Microglobulin; D014598:Uteroglobin